(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Hyperlipidemias D006949 73 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Weight Loss D015431 56 associated lipids
Parkinson Disease D010300 53 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Fatty Liver D005234 48 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Starvation D013217 47 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Lung Diseases D008171 37 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Epilepsy D004827 35 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Uremia D014511 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Hypothyroidism D007037 32 associated lipids
Liver Diseases D008107 31 associated lipids
Obesity D009765 29 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Hyperinsulinism D006946 27 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Mitochondrial Diseases D028361 25 associated lipids
Cattle Diseases D002418 24 associated lipids
Cholestasis D002779 23 associated lipids
Hypoxia D000860 23 associated lipids
Birth Weight D001724 23 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Hyperglycemia D006943 21 associated lipids
Vomiting D014839 21 associated lipids
Cachexia D002100 21 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Pregnancy Complications D011248 19 associated lipids
Albuminuria D000419 18 associated lipids
Parkinson Disease, Secondary D010302 17 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Diabetic Ketoacidosis D016883 16 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Brain Neoplasms D001932 15 associated lipids
Reye Syndrome D012202 14 associated lipids
Glucose Intolerance D018149 13 associated lipids
Acidosis D000138 13 associated lipids
Ketosis D007662 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Hypoglycemia D007003 13 associated lipids
Critical Illness D016638 13 associated lipids
Hypocalcemia D006996 12 associated lipids
Disease Resistance D060467 12 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Death, Sudden D003645 12 associated lipids
Cat Diseases D002371 12 associated lipids
Metabolic Diseases D008659 12 associated lipids
Dehydration D003681 11 associated lipids
Thinness D013851 11 associated lipids
Shock D012769 11 associated lipids
Congenital Abnormalities D000013 11 associated lipids
Amyotrophic Lateral Sclerosis D000690 11 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Fatigue D005221 10 associated lipids
Glycosuria D006029 10 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Sheep Diseases D012757 10 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Infant, Newborn, Diseases D007232 9 associated lipids
Hyperlipidemia, Familial Combined D006950 9 associated lipids
Trematode Infections D014201 8 associated lipids
Anorexia D000855 8 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastitis, Bovine D008414 8 associated lipids
Obesity, Morbid D009767 8 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Bell FP et al. Carnitine metabolism in Macaca arctoides: the effects of dietary change and fasting on serum triglycerides, unesterified carnitine, esterified (acyl) carnitine, and beta-hydroxybutyrate. 1982 Am. J. Clin. Nutr. pmid:7091021
Jeukendrup AE et al. Effect of medium-chain triacylglycerol and carbohydrate ingestion during exercise on substrate utilization and subsequent cycling performance. 1998 Am. J. Clin. Nutr. pmid:9497182
Binnert C et al. Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. 1998 Am. J. Clin. Nutr. pmid:9537605
Rosen JC et al. Mood and appetite during minimal-carbohydrate and carbohydrate-supplemented hypocaloric diets. 1985 Am. J. Clin. Nutr. pmid:4036844
Freinkel N et al. The 1986 McCollum award lecture. Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. 1986 Am. J. Clin. Nutr. pmid:3788845
Vazquez JA et al. Protein metabolism during weight reduction with very-low-energy diets: evaluation of the independent effects of protein and carbohydrate on protein sparing. 1995 Am. J. Clin. Nutr. pmid:7598072
Musa-Veloso K et al. Breath acetone is a reliable indicator of ketosis in adults consuming ketogenic meals. 2002 Am. J. Clin. Nutr. pmid:12081817
Hinderling VB et al. The effect of etomoxir on 24-h substrate oxidation and satiety in humans. 2002 Am. J. Clin. Nutr. pmid:12081827
Pollitt E et al. Brief fasting, stress, and cognition in children. 1981 Am. J. Clin. Nutr. pmid:7270476
Seng G et al. Metabolic effects of a single administration of growth hormone on lipid and carbohydrate metabolism in normal-weight and obese subjects. 1989 Am. J. Clin. Nutr. pmid:2596425
Kamphuis MM et al. Diacylglycerols affect substrate oxidation and appetite in humans. 2003 Am. J. Clin. Nutr. pmid:12716663
Seaton TB et al. Thermic effect of medium-chain and long-chain triglycerides in man. 1986 Am. J. Clin. Nutr. pmid:3532757
Sevastianova K et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. 2011 Am. J. Clin. Nutr. pmid:21525193
Zauner C et al. Resting energy expenditure in short-term starvation is increased as a result of an increase in serum norepinephrine. 2000 Am. J. Clin. Nutr. pmid:10837292
Bortolotti M et al. High protein intake reduces intrahepatocellular lipid deposition in humans. 2009 Am. J. Clin. Nutr. pmid:19710199
Chioléro R et al. Effects of infused sodium acetate, sodium lactate, and sodium beta-hydroxybutyrate on energy expenditure and substrate oxidation rates in lean humans. 1993 Am. J. Clin. Nutr. pmid:8237864
Vazquez JA et al. Intravenously infused carnitine: influence on protein and branched-chain amino acid metabolism in starved and parenterally fed rats. 1988 Am. J. Clin. Nutr. pmid:3137800
Robertson MD et al. Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism. 2002 Am. J. Clin. Nutr. pmid:11864856
Kripke SA et al. Experimental short-bowel syndrome: effect of an elemental diet supplemented with short-chain triglycerides. 1991 Am. J. Clin. Nutr. pmid:1706907
Foreback CC Beta-hydroxybutyrate and acetoacetate levels. 1997 Am. J. Clin. Pathol. pmid:9353103